Mechanistic studies reveal that PRL-3 functions as an initiator of neoplastic angiogenesis by recruiting endothelial cells [18] and stimulates invasion and motility of tumor cells through activating the Rho family of small GTPases such as RhoA and RhoC [22]. Here, RHOC is linked to neoplasm.